Skip to main content
TipRanks
Go Ultimate75% OFF

Polaris (PL6) Drug Pipeline

0 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Adi-Peg20Nonalcoholic Steatohepatitis (Nash)Phase IIRecruitingStudy of ADI-PEG 20 Versus Placebo in Subjects With NASHJan 20, 2023―
Adi Peg20Soft Tissue SarcomaPhase IIIRecruitingStudy of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)Dec 13, 2022―
Adi-Peg20Hepatocellular Carcinoma, Advanced Hepatocellular CarcinomaPhase IIIRecruitingStudy of ADI-PEG 20 Versus Placebo in Subjects with High Arginine Level and Unresectable Hepatocellular CarcinomaApr 01, 2022―
Temozolomide, Adi-Peg 20Glioblastoma Multiforme (Gbm)Phase IIActive Not RecruitingADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma MultiformeSep 04, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Polaris Industries (DE:PL6) have in its pipeline
Polaris DE:PL6 is currently developing the following drugs: Adi-Peg20, Adi Peg20, Temozolomide, Adi-Peg 20. These drug candidates are in various stages of clinical development as the company works toward FDA approval.